ARCA:PBE
Invesco Biotechnology & Genome ETF | |
| $ 89.6886 1.5769 ( +1.79%) 03:57 PM EST | |
PE Ratio:
19.89
PB Ratio:
3.75
Volume:
14.66K
Dividend Yield %:
1.5
| |
| Last Holding update 2026-06-26 | 30 Stocks (3 new) |
| Value $248.00 Mil | Turnover 12 % |
Registrant: Invesco Biotechnology & Genome ETF
| |
Year: 2026
GuruFocus Rankings
Financial Strength
7 /10
Profitability Rank
6 /10
GF Value Rank
6 /10
Growth Rank
7 /10
Momentum Rank
6 /10
Invesco Biotechnology & Genome ETF Geographic Breakdown
Invesco Biotechnology & Genome ETF Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Invesco Biotechnology & Genome ETF Key Statistics
| Name | Value | ||
|---|---|---|---|
| Day's Open ($) | 88.12 | ||
| Day's Range ($) | 88.12 - 90.33 | ||
| Day's Volume | 14,656 | ||
| 52-Week Range ($) | 63.6847 - 90.33 | ||
| Beta | 0.7988 | ||
| 3-Year Sharpe Ratio | 0.48 | ||
| 3-Year Sortino Ratio | 0.84 | ||
| Volatility | 14.07 | ||
| 14-Day RSI | 73.22 | ||
| 14-Day ATR ($) | 1.437724 | ||
| 20-Day SMA ($) | 84.50046 |
Fundamental Data
| Name | Value | ||
|---|---|---|---|
| Market Cap (Mil $) | 277.138 | ||
| Shares Outstanding (Mil) | 3.09 | ||
| PE Ratio | 19.89 | ||
| PE Ratio (10y Range) | - | ||
| PE Ratio (10y Median) | - | ||
| PB Ratio | 3.75 | ||
| PB Ratio (10y Range) | - | ||
| PB Ratio (10y Median) | - |
Dividend Data
| Name | Value | ||
|---|---|---|---|
| Dividends per Share (TTM) ($) | - | ||
| Dividend Yield % | 1.5 | ||
| Dividend Yield % (10y Range) | - | ||
| Dividend Yield % (10y Median) | - | ||
| Next Dividend Payment Date | |||
| Dividend Frequency | Quarterly |
PBE Invesco Biotechnology & Genome ETF Fundamental Charts
Historical TTM Price-to-Earnings for PBE Invesco Biotechnology & Genome ETF
Historical TTM Price-to-Earnings without NRI for PBE Invesco Biotechnology & Genome ETF
Historical Price-to-Book Ratio for PBE Invesco Biotechnology & Genome ETF
Historical Dividend Yields for PBE Invesco Biotechnology & Genome ETF
Invesco Biotechnology & Genome ETF Technical Indicators
Moving Average
Momentum
Gurus Latest Trades with ARCA:PBE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
ARCA:PBE is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Invesco Biotechnology & Genome... Top Holdings of 2026-04-30
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
UTHR | United Therapeutics Corp | 27,212 | 15,547.6 | -0.11% | 6.280 | -0.01% | 0.060 | +1.83% | +11.29% | 23,018.0 | Drug Manufacturers | |
ILMN | Illumina Inc | 104,832 | 13,286.4 | +1.58% | 5.370 | +0.08% | 0.070 | +41.92% | +34.61% | 26,712.0 | Medical Diagnostics & Research | |
BIIB | Biogen Inc | 66,025 | 12,497.2 | -10.19% | 5.050 | -0.51% | 0.040 | +13.07% | +22.75% | 31,894.0 | Drug Manufacturers | |
INCY | Incyte Corp | 127,499 | 12,146.8 | +4.20% | 4.910 | +0.20% | 0.060 | +23.30% | +15.18% | 22,727.2 | Biotechnology | |
ALNY | Alnylam Pharmaceuticals Inc | 38,706 | 11,979.1 | +29.30% | 4.840 | +1.10% | 0.030 | -11.21% | -26.73% | 38,901.6 | Biotechnology | |
REGN | Regeneron Pharmaceuticals Inc | 16,684 | 11,796.6 | -2.27% | 4.770 | -0.11% | 0.020 | -16.24% | -17.78% | 66,352.6 | Biotechnology | |
AMGN | Amgen Inc | 33,651 | 11,651.7 | -13.46% | 4.710 | -0.68% | 0.010 | +2.23% | +11.07% | 193,393.7 | Drug Manufacturers | |
GILD | Gilead Sciences Inc | 87,264 | 11,417.6 | -15.91% | 4.610 | -0.89% | 0.010 | -5.96% | +5.47% | 158,772.0 | Drug Manufacturers | |
BCRX | BioCryst Pharmaceuticals Inc | 923,458 | 8,458.9 | -11.05% | 3.420 | -0.29% | 0.360 | +4.29% | +27.82% | 2,534.0 | Drug Manufacturers | |
CPRX | Catalyst Pharmaceuticals Inc | 290,513 | 8,172.1 | -3.68% | 3.300 | -0.10% | 0.240 | +29.90% | +34.96% | 3,856.2 | Biotechnology |
Invesco Biotechnology & Genome ETF's Historical Top Holdings Breakdowns
Invesco Biotechnology & Genome ETF's Top Stock Picks
View Full List
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FOLD Unlock Delisted | Amicus Therapeutics Inc | 2026-04-30 | Sold Out Sold Out | -3.90% | 14.27 ($14.39) 14.49 | $14.49 | 0.69% | Sold Out | 0 | -716,939 | |
| DVAX Unlock Delisted | Dynavax Technologies Corp | 2026-04-30 | Sold Out Sold Out | -3.65% | 15.48 ($15.5) 15.51 | $15.50 | 0% | Sold Out | 0 | -619,803 | |
ARWR | Arrowhead Pharmaceuticals Inc | 2026-04-30 | New Buy New Buy | +3.28% | 55.01 ($63.87) 74.4 | $79.03 | 23.74% | New holding | 110,374 | 110,374 | |
CDNA | CareDx Inc | 2026-04-30 | New Buy New Buy | +3.07% | 16.05 ($18.77) 22.42 | $28.76 | 53.22% | New holding | 365,065 | 365,065 | |
TBPH | Theravance Biopharma Inc | 2026-04-30 | New Buy New Buy | +2.49% | 13.57 ($16.7) 20.48 | $17.64 | 5.63% | New holding | 368,704 | 368,704 | |
MDGL | Madrigal Pharmaceuticals Inc | 2026-04-30 | Sold Out Sold Out | -2.24% | 425.85 ($480.7) 546.89 | $512.65 | 6.65% | Sold Out | 0 | -12,061 | |
ALNY | Alnylam Pharmaceuticals Inc | 2026-04-30 | Add Add | +1.10% | 301.19 ($322.29) 351.96 | $291.37 | -9.59% | Add 29.3% | 38,706 | 8,770 | |
GILD | Gilead Sciences Inc | 2026-04-30 | Reduce Reduce | -0.89% | 127.75 ($142.58) 155.8 | $127.88 | -10.31% | Reduce -15.91% | 87,264 | -16,506 | |
AMGN | Amgen Inc | 2026-04-30 | Reduce Reduce | -0.68% | 338.02 ($360.13) 388.16 | $358.33 | -0.50% | Reduce -13.46% | 33,651 | -5,234 | |
VCYT | Veracyte Inc | 2026-04-30 | Add Add | +0.60% | 30.01 ($34.02) 38.75 | $60.38 | 77.48% | Add 29.68% | 196,903 | 45,071 |
Invesco Biotechnology & Genome ETF Total Holding History ($B)
Invesco Biotechnology & Genome ETF's Asset Allocation
Invesco Biotechnology & Genome ETF Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
Invesco Biotechnology & Genome ETF's Hypothetical Growth since 2026-04-30
Invesco Biotechnology & Genome ETF's Yearly Returns
This information is only displayed for Gurus who publicly disclose audited performance records; most hedge funds and private investment firms do not publish such data or only provide limited historical performance information.
| Year | Portfolio % | % | Excess Gain % |
|---|
Invesco Biotechnology & Genome ETF's Holdings Heat Map
Size field: